بعد از

در این صفحه تعداد 118 مقاله تخصصی درباره بعد از که در نشریه های معتبر علمی و پایگاه ساینس دایرکت (Science Direct) منتشر شده، نمایش داده شده است. برخی از این مقالات، پیش تر به زبان فارسی ترجمه شده اند که با مراجعه به هر یک از آنها، می توانید متن کامل مقاله انگلیسی همراه با ترجمه فارسی آن را دریافت فرمایید.
در صورتی که مقاله مورد نظر شما هنوز به فارسی ترجمه نشده باشد، مترجمان با تجربه ما آمادگی دارند آن را در اسرع وقت برای شما ترجمه نمایند.
مقالات ISI بعد از (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; 18FDG; 18-fluoro-2-deoxy-d-glucose; hs-CRP; high-sensitivity C-reactive protein; PASI; Psoriasis Area Severity Index; PET/CT; position emission tomography-computed tomography; TBR; target-to-background ratio; TNF-α; tumor necrosis factor alpha;
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; BIOBADADERM; Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases; CI; confidence interval; PASI; Psoriasis Area Severity Index; RR; risk ratio; TNF; tumor necrosis factor;
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; itch; itch numeric rating scale; patient-reported outcomes; psoriasis; skin appearance bothersomeness; skin pain; HRQoL; health-related quality of life; NRS; numeric rating scale; PASI; Psoriasis Area and Severity Index; PRO; patient-reported outcome; PSA
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; apremilast; difficult to treat; ESTEEM; moderate to severe; palmoplantar psoriasis; palms; PSOR-005; soles; ESTEEM; Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis; IL; interleukin; m-PPPASI; modified Palmoplantar Psoriasis Are
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; chronic plaque psoriasis; HLA-Cw*0602; Psoriasis Disability Index; Psoriasis Life Stress Inventory; sore throat; streptococcal throat infection; tonsillectomy; PASI; Psoriasis Area and Severity Index; PDI; Psoriasis Disability Index; PLSI; Psoriasis Life
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; apremilast; nail psoriasis; phosphodiesterase 4 inhibitor; psoriasis; scalp psoriasis; systemic therapy; BID; twice daily; ESTEEM; Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis; NAPSI; Nail Psoriasis Severity Index; NAPSI-50;
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; efficacy; Janus kinase inhibitor; long-term; psoriasis; randomized controlled trial; safety; tofacitinib; AE; adverse event; BID; twice daily; CI; confidence interval; HZ; herpes zoster; IR; incidence rate; LTE; long-term extension; NMSC; nonmelanoma skin
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; adalimumab; etanercept; failure; infliximab; psoriasis; switching; tumor necrosis factor antagonist; DLQI; Dermatology Life Quality Index; PASI; Psoriasis Area and Severity Index; PASI50; 50% improvement in Psoriasis Area and Severity Index score; PASI75;
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; CTLA4; cytotoxic T-lymphocyte-associated protein 4; DEG; differentially expressed gene; FDR; false discovery rate; GSVA; gene set variation analysis; K16; keratin 16; PASI; Psoriasis Area and Severity Index; TH; T helper; Treg; regulator T cell;
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; HLA; human leukocyte antigen; HLA-C*06:02-POS; HLA-C*06:02-positive; HLA-C*06:02-NEG; HLA-C*06:02-negative; PASI; Psoriasis Area and Severity Index; PASI 50/75/70; 50/75/90% improvement from baseline in Psoriasis Area and Severity Index; TNF; tumor necros
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; clear or almost clear skin; clinical trial; head to head; plaque psoriasis; secukinumab; superiority; ustekinumab; 90% or more improvement in baseline Psoriasis Area and Severity Index; AE; adverse event; DLQI; Dermatology Life Quality Index; HRQoL; healt
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; adolescent; biologic; children; pediatric; psoriasis; systemic therapy; ustekinumab; AE; adverse event; CDLQI; Children's Dermatology Life Quality Index; HRQoL; health-related quality of life; HSD; half-standard dose; PASI; Psoriasis Area and Severity Ind
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; clinical trial; dosing; immunogenicity; noninferiority; psoriasis; retreatment as needed; secukinumab; AE; adverse event; DLQI; Dermatology Life Quality Index; IGA; investigator global assessment; PASI; Psoriasis Area and Severity Index; PASI 75; 75% or m
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; IL-23A; mAb; psoriasis; pharmacokinetics; biomarkers; single dose; randomized; AE; Adverse event; AUEC; Area under the effect curve; DC-LAMP; Dendritic cell lysosome-associated membrane glycoprotein; Emax; Maximum effect; FC; Fold change; MACE; Major adve
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; interleukin 17; ixekizumab; long-term; monoclonal antibodies; open label; psoriasis; 1 year; AE; adverse event; NRI; nonresponder imputation; OLE; open-label extension; PASI; Psoriasis Area and Severity Index; PASI75; 75% improvement from baseline on the
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; anti-CD6; autoimmune disease; itolizumab; monoclonal antibody; psoriasis; Psoriasis Area and Severity Index; ADA; antidrug antibody; AE; adverse event; PASI; Psoriasis Area and Severity Index; PASI 75; at least 75% improvement in Psoriasis Area and Severi
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; cardiovascular risk; matrix metalloproteinase-9; myeloperoxidase; psoriasis; soluble E-selectin; soluble intercellular adhesion molecule-1; soluble vascular cell adhesion molecule-1; total plasminogen activator inhibitor-1; tumor necrosis factor-alfa inhi
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; biologics; efficacy; primary inefficacy; psoriasis; secondary loss of efficacy; switching; tumor necrosis factor-alfa inhibitors; PASI; Psoriasis Area Severity Index; PASI 75; 75% improvement in the Psoriasis Area Severity Index score; TNF; tumor necrosis
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; Histology; IL-23; gene expression; guselkumab; psoriasis; Psoriasis Area and Severity Index; serum; skin; T cell; TH17; AE; Adverse event; DC; Dendritic cell; IL-12Rβ1; IL-12 receptor β1; IL-23R; IL-23 receptor; KRT16; Keratin 16; LCN2; Lipocalin 2; PAS
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; Cap; Capsaicin; C-CyLiPn; Cap encapsulated CyLiPn; CGRP; Calcitonin gene related peptide; CLSM; Confocal laser scanning microscopy; CS-CyLiPn; Cap + siTNFα incorporated CyLiPn; CyLiPn; Lipid-polymer nanocarriers; FACS; Fluorescence-activated cells sort
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; arterial intima-media thickness; atherosclerosis; cardiovascular risk; high-resolution B-mode ultrasonography; psoriasis vulgaris; tumor necrosis factor-alfa inhibitorCT, computed tomography; FDG, 18F-fluoro-deoxyglucose; IMT, intima-media thickness; PASI
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; biologic therapy; etanercept; PASI; plaque psoriasis; PSSI; randomized controlled trial; scalp symptoms; tumor necrosis factor antagonistAE, adverse event; BIW, twice weekly; BMI, body mass index; BSA, body surface area; IL, interleukin; ITT, intent-to-tr
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; adalimumab; biologic therapy; cost savings; disease severity; psoriasis; work productivity and activity impairment; DLQI; Dermatology Life Quality Index; PASI; Psoriasis Area and Severity Index; PGA; Physician Global Assessment; REVEAL; randomized control
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; adalimumab; anti-tumor necrosis factor therapy; clinical trial; efficacy; long-term treatment; open-label; psoriasis; safety; AE; adverse events; eow; every other week; LOCF; last observation carried forward; OLE; open-label extension; PASI; Psoriasis A
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; biological therapy; etanercept; psoriasis; safety; tumor necrosis factor; AE; adverse event; BCC; basal cell carcinoma; BIW; twice weekly; CI; confidence interval; DLQI; Dermatology Life Quality Index; NMSC; nonmelanoma skin cancer; PASI; Psoriasis Area a
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; PsA; Psoriatic arthritis; NAFLD; non-alcoholic fatty liver disease; NASH; non-alcoholic steatohepatitis; Ps-NAFLD; NAFLD associated with psoriasis; PASI; psoriasis area and severity index; BMI; body mass index; ALT; alanine aminotransferase; AST; aspartat
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; CBT, cognitive–behavioral therapy; PASI, Psoriasis Area and Severity Index; DLQI, Dermatology Life Quality Index; POMS, Profile of Mood States; HADS, Hospital Anxiety and Depression ScaleDistress; Emotional disclosure; Mood; PASI; Psoriasis; Quality of li
Elsevier - ScienceDirect - الزویر - ساینس دایرکت
Keywords: بعد از; ALT; alanine aminotransferase; AST; aspartate aminotransferase; ANOVA; analysis of variance; BSA; body surface area; DLQI; Dermatology Life Quality Index; EXPRESS; European Infliximab for Psoriasis (Remicade) Efficacy and Safety Study; EXPRESS II; Evaluat